News
Financial Stability: Eli Lilly's balance sheet is more robust, with debt making up only 4% of equity, considerably less than ...
In collaboration with Eli Lilly and Company (NYSE:LLY), a pharmaceutical company recognized globally for its innovative ...
BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 ...
A significant trading signal occurred for Eli Lilly stock, as it demonstrated a power inflow at $734.98, after which LLY rose ...
This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...
The Fluor team constructing the Eli Lilly and Co. pharmaceutical complex on Lebanon's north side recognized national Safety ...
DelveInsight's "FILSPARI Market Size, Forecast, and Market Insight Report" highlights the details around FILSPARI, the first and only ...
The stock's rise snapped a five-day losing streak.
Eli Lilly will acquire privately held SiteOne Therapeutics, the companies said on Tuesday, giving the drugmaker access to an ...
Winkler said her company would like to help New Palestine leaders be more intentional with their branding. Winkler said the ...
Myasthenia gravis is an autoimmune disorder in which antibodies disrupt the communication between nerves and muscles, ...
Shares of Eli Lilly & Co. LLY shed 1.34% to $715.20 Thursday, on what proved to be an all-around rough trading session for the stock market, with the Dow Jones Industrial Average DJIA remaining mostly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results